F.D.A. Approves First Drug to Treat Severe Multiple Sclerosis

Jerrie Gullick, 51, was part of the clinical trial for Ocrevus and said the drug had significantly slowed the progression of her primary progressive multiple sclerosis. Credit Sam Hodgson for The New York Times


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.